In 2023, the total revenue of the Italian pharmaceutical group Recordati amounted to over two billion euros, most of which came from the production and marketing of specialty medicines. Rare diseases drugs were the category generating the largest revenues, with over 714 million euros, followed by the branded drug Zanidip, which generated revenue for around 145 million euros. This statistic breaks down the revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros).
Revenue of Italian pharmaceutical company Recordati in 2023, by product
(in 1,000 euros)
Characteristic
Revenue in thousand euros
Drugs for rare diseases
714,720
Zanidip
144,959
Eligard
110,682
Seloken/Seloken ZOK/Logimax
97,983
Urorec
70,038
Livazo
44,616
Zanipress
36,412
Avodart (dutasteride) and Combodart/Duodart (dutasteride/tamsulosin)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Recordati. (April 23, 2024). Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) [Graph]. In Statista. Retrieved November 09, 2024, from https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. "Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros)." Chart. April 23, 2024. Statista. Accessed November 09, 2024. https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. (2024). Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros). Statista. Statista Inc.. Accessed: November 09, 2024. https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. "Revenue of Italian Pharmaceutical Company Recordati in 2023, by Product (in 1,000 Euros)." Statista, Statista Inc., 23 Apr 2024, https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati, Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) Statista, https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/ (last visited November 09, 2024)
Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) [Graph], Recordati, April 23, 2024. [Online]. Available: https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
